Table 2.
Author/year | Scanner (rows) | Patients (n) | Stents (n) | Non evaluable (%) | Sensitivity (%) | Specificity (%) | PPV (%) | NPV (%) |
---|---|---|---|---|---|---|---|---|
Maintz et al. 2003 [23] | 4 | 29 | 47 | 19.1 | 100 | 100 | 100 | 100 |
Krüger et al. 2003 [21] | 4 | 20 | 32 | 0 | 100 | 100 | 100 | 100 |
Ligabue et al. 2004 [24] | 4 | 48 | 72 | 17.8 | 100 | 100 | 100 | 100 |
Mazzarotto et al. 2006 [25] | 4 | 24 | 34 | 9.4 | 91.3 | 66.6 | 95.5 | 50 |
Schuijf et al. 2004 [26] | 16 | 22 | 68 | 23 | 75 | 96 | na | na |
Gilard et al. 2005 [27] | 16 | 29 | 29 | 7 | 100 | 93 | 100 | 93 |
Cademartiri et al. 2005 [28] | 16 | 51 | 74 | na | 83.3 | 98.5 | 83.3 | 97.3 |
Watanabe et al. 2006 [29] | 16 | 31 | 42 | 16.7 | 83 | 90 | 63 | 96 |
Gilard et al. 2006 [30] | 16 | 143 | 128 (≤3 mm) | 45.7 | 54 | 100 | 100 | 94 |
104 (<3 mm) | 86 | 100 | 100 | 99 | ||||
Kitagawa et al. 2006 [31] | 16 | 42 | 61 | 31.1 | 100(1) | 100(1) | 100(1) | 100(1) |
Ohnuki et al. 2006 [32] | 16 | 16 | 20 | 5 | 75 | 88 | 75 | 93 |
Kefer et al. 2007 [33] | 16 | 50 | 73 | na | 67 | 98 | 92 | 89 |
Chabbert et al. 2007 [34] | 16 | 134 | 145 | 8.3 | 90.5(2) | 66.5(2) | 42(2) | 96(2) |
Soon et al. 2007 [35] | 16 | 37 | 47 | 4 | 71 | 97 | 83 | 95 |
Mühlenbruch et al. 2007 [36](3) | 16 | 14 | 20 | na | 100 | 100 | 100 | 100 |
Tedeschi et al. 2008 [37] | 16 | 72 | 90 | 21 | 82 | 96 | 87 | 94 |
Kitagawa et al. 2008 [38] | 16 | 38 | 47 | 26 | 100 | 74 | 67 | 100 |
Gaspar et al. 2005 [39] | 40 | 65 | 111 | 4.5 | 74.1 | 83.3 | 58.8 | 90.9 |
| ||||||||
Total/mean | 264 | 865 | 18.1 | 82.0 | 90.7 | 83.6 | 93.9 |
na: not available; PPV: positive predictive value; NPV: negative predictive value; (1)subgroup of 21 assessable stents with angiographic correlation; (2)mean of two observers; (3)only CABG stents.